Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: A randomized placebo-controlled trial

Retina

Volumn 31, Issue 7, 2011, Pages 1378-1386

  Wu, Zenith H Y ^a   Lai, Ricky Y K ^a   Yip, Yolanda W Y ^a   Chan, Wai Man ^a   Lam, Dennis S C ^a   Lai, Timothy Y Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

central serous chorioretinopathy; multifocal electroretinography; photodynamic therapy; verteporfin

Indexed keywords

PLACEBO; VERTEPORFIN;

ACUTE DISEASE; ADULT; AMPLITUDE MODULATION; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; HUMAN; MALE; MULTIFOCAL ELECTRORETINOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; RETINA FOVEA; VISUAL ACUITY;

EID: 85028105256     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31820beb02     Document Type: Article

References (38)

1. Gass JD. Pathogenesis of disciform detachment of neuroepithelium. Am J Ophthalmol 1967;63:587-615.
2. Yannuzzi LA. Type-A behaviour and central serous chorioretinopathy. Retina 1987;7:111-131. (Pubitemid 17136150)
3. Cardillo Piccolino F, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-242. (Pubitemid 24308054)
4. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34. (Pubitemid 26026078)
5. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green angiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-1062. (Pubitemid 24272611)
6. Watzke RC, Burton TC, Leaverton PE. Ruby laser photocoagulation therapy of central serous retinopathy. I. A controlled clinical study. II. Factors affecting prognosis. Trans Am Acad Ophthalmol Otolaryngol 1974;78:OP205-OP211.
7. Watzke RC, Burton TC, Woolson RF. Direct and indirect laser photocoagulation of central serous choroidopathy. Am J Ophthalmol 1979;88:914-918. (Pubitemid 10236340)
8. Burumeck E, Mudun A, Karacorlu S, Arslan MO. Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 1997;104:616-622. (Pubitemid 27171982)
9. Robertson DM. Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology 1986;93:972-974. (Pubitemid 16046110)
10. Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983;95:457-466. (Pubitemid 13128571)
11. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003;23:235-237. (Pubitemid 36548818)
12. Canakis C, Livir-Rallatos C, Panayiotis Z, et al. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Ophthalmol 2003;136:750-752. (Pubitemid 37153200)
13. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003;23:752-763. (Pubitemid 38040573)
14. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003;23:288-298. (Pubitemid 36792972)
15. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458. (Pubitemid 38010546)
16. Taban M, Boyer DS, Thomas EL, Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004:137:1073-1080. (Pubitemid 38759356)
17. Ober MD, Yannuzzi LA, Do DV, et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005;12:2088-2094. (Pubitemid 41720985)
18. Kim KS, Lee WK. Photodynamic therapy with verteporfin for avascular serous pigment epithelial detachment in elderly Koreans. Retina 2010;30:93-99.
19. Colucciello M. Choroidal neovascularization complicating photodynamictherapyforcentral serousretinopathy.Retina2006;26:239-242. (Pubitemid 44400737)
20. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS. Safety enhanced photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 2006;90:869-874. (Pubitemid 43973998)
21. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 2008;28:85-93.
22. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 2008;115:1756-1765.
23. Koytak A, Erol K, Coskun E, Asik N, Ozturk H, Ozerturk Y. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy. Retina 2010;30:1698-1703.
24. Sutter EE, Tran D. The field topography of ERG components in man-I. The photopic luminance response. Vision Res 1992; 32:433-446.
25. Lai TY, Chan WM, Lai RY, Ngai JW, Li H, Lam DS. The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol 2007;52:61-96. (Pubitemid 46038359)
26. Marmor MF, Tan F. Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol 1999;117:184-188. (Pubitemid 29091812)
27. Chappelow AV, Marmor MF. Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy. Arch Ophthalmol 2000;118:1211-1215.
28. Suzuki K, Hasegawa S, Usui T, et al. Multifocal electroretinogram in central serous chorioretinopathy. Jpn J Ophthalmol 2000;44:571.
29. Vajaranant TS, Szlyk JP, Fishman GA, Gieser JP, Seiple W. Localized retinal dysfunction in central serous chorioretinopathy as measured using the multifocal electroretinogram. Ophthalmology 2002;109:1243-1250. (Pubitemid 34700913)
30. Huang S, Wu D, Jiang F, et al. The multifocal electroretinogram in central serous chorioretinopathy. Ophthalmic Physiol Opt 2002;22:244-247. (Pubitemid 41711154)
31. Moschos M, Brouzas D, Koutsandrea C, et al. Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography. Ophthalmologica 2007;221:292-298. (Pubitemid 47339651)
32. Lai TY, Lai RY, Ngai JW, Chan WM, Li H, Lam DS. First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy. Doc Ophthalmol 2008;116:29-40. (Pubitemid 351167829)
33. Yip YW, Ngai JW, Fok AC, et al. Correlation between functional and anatomical assessments by multifocal electroretinography and optical coherence tomography in central serous chorioretinopathy. Doc Ophthalmol 2010;120:193-200.
34. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmologica 2008;116:1-11.
35. Lai TY, Chan WM, Lam DS. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 2004;137:826-833. (Pubitemid 38582034)
36. Tsuchihashi T, Mori K, Peyman G, Shimada Y, Yoneya S. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration. Retina 2009;29:1450-1456.
37. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res 2000;19:607-646. (Pubitemid 30488087)
38. Zhao MW, Zhou P, Xiao HX, et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin. Retina 2009;29:1155-1161.